MONOFOS MONOSODIUM PHOSPHATE

Main information

  • Trade name:
  • MONOFOS MONOSODIUM PHOSPHATE
  • Class:
  • Veterinary Medicine
  • Medicine domain:
  • Animals
  • Medicine type:
  • Allopathic drug

Documents

Localization

  • Available in:
  • MONOFOS MONOSODIUM PHOSPHATE
    Australia
  • Language:
  • English

Therapeutic information

  • Therapeutic group:
  • LIVESTOCK ANIMALS | CATTLE | HORSES | SHEEP
  • Therapeutic area:
  • NUTRITION & METABOLISM
  • Therapeutic indications:
  • MINERAL AND NUTRITIONAL ADDITIVE | ACETONAEMIA | ACTINOBACILLOSIS | AMINO ACID SUPPLEMENT | AMINO ACIDS | BONE FRAGILITY | BONE GROWTH | CALCIUM SUPPLEMENT | CARTILAGE STRENGTH | COPPER DEFICIENCY | EGG SHELL | FATTY ACID DEFICIENCY | FATTY LIVER | GLUCOSE | GRASS TETANY | HEPATOTOXIC DRUGS | HYPOCALCAEMIA | HYPOMAGNESAEMIA | ILEITIS | IODINE DEFICIENCIES | LACTATING | LAXATIVE | L-CARNITINE SUPPLEMENT | LIVER ABSCESS | LIVER DAMAGE | LYSINE DEFICIENCIES | MILK FEVER | MINERAL ADDITIVE | MYOPATHIES | MYOSITIS SYNDROME | PANGAMIC ACID | PHOSPHOROUS SUPPLEMENT | RICKETS | SELENIUM DEFICIENCY | SHELL STRENGTH | SOFT BONE DISEASE | VITAMIN B12 | VITAMIN D SUPPLEMENT | VITAMIN E DEFICIENCIES | ZINC DEFICIENCIES

Other information

Status

  • Source:
  • Australian Pesticides and Veterinary Medicines Authority (APVMA)
  • Authorization status:
  • Archived
  • Authorization number:
  • 35561
  • Last update:
  • 09-08-2016

19-12-2018

Safety and efficacy of vitamin B2 (riboflavin 5′‐phosphate ester monosodium salt) for all animal species when used in water for drinking

Safety and efficacy of vitamin B2 (riboflavin 5′‐phosphate ester monosodium salt) for all animal species when used in water for drinking

Published on: Tue, 18 Dec 2018 Following a request from the European Commission, the Panel on Additives and Products or Substances used in Animal Feed (FEEDAP) was asked to deliver a scientific opinion on vitamin B2 in the form of riboflavin 5′‐phosphate ester monosodium salt as an additive for all animal species for use in water for drinking. The additive under assessment is obtained from ■■■■■ a source of riboflavin produced by Ashbya gossypii. No information was provided on the identity and character...

Europe - EFSA - European Food Safety Authority EFSA Journal

10-8-2018

Sivextro (Merck Sharp and Dohme B.V.)

Sivextro (Merck Sharp and Dohme B.V.)

Sivextro (Active substance: tedizolid phosphate) - Centralised - Transfer Marketing Authorisation Holder - Commission Decision (2018)5522 of Fri, 10 Aug 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/2846/T/28

Europe -DG Health and Food Safety

2-8-2018

EU/3/18/2047 (Glycomine SARL)

EU/3/18/2047 (Glycomine SARL)

EU/3/18/2047 (Active substance: Liposomal mannose-1-phosphate) - Orphan designation - Commission Decision (2018)5279 of Thu, 02 Aug 2018 European Medicines Agency (EMA) procedure number: EMA/OD/055/18

Europe -DG Health and Food Safety

27-6-2018

EU/3/02/124 (BioMarin International Limited)

EU/3/02/124 (BioMarin International Limited)

EU/3/02/124 (Active substance: 3,4-diaminopyridine phosphate) - Transfer of orphan designation - Commission Decision (2018)4095 of Wed, 27 Jun 2018 European Medicines Agency (EMA) procedure number: EMA/OD/050/02/T/03

Europe -DG Health and Food Safety